Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+47.3%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+47.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$69.19M+32.1%
2024$52.37M+126.7%
2023$23.10M+6.8%
2022$21.64M+64.1%
2021$13.19M+139.8%
2020$-33.09M-2257.3%
2019$1.53M-
2018$0.00-100.0%
2017$141215.00-
2016$0.00-